Literature DB >> 21345534

[Laboratory diagnosis of HIV infection, viral tropism and resistance to antiretrovirals].

Federico García1, Marta Álvarez, Carmen Bernal, Natalia Chueca, Vicente Guillot.   

Abstract

The accurate diagnosis of HIV infection demands that to consider a positive result, at least three assays with different antigenic base should be used, one of them, Western-Blot being mandatory for confirmation. Fourth generation ELISAs shorten the window phase to 13-15 days, as they now include p24 antigen detection. Proviral DNA or Viral RNA detection by molecular methods have proved useful for addressing complex situations in which serology was inconclusive. Viral load (HIV-RNA) is routinely used to follow-up HIV infected patients and is used for treatment initiation decisions. It is also used to monitor viral failure. When this happens, resistance tests are needed to guide treatment changes. Resistance is also used to assess the transmission of drug resistance to newly diagnosed patients. Finally, before using an anti-CCR5 drug, viral tropism needs to be determined. This can be done using genotypic tests, widely available in many HIV labs, or phenotypic tests, only available at certain sites.
Copyright © 2010 Elsevier España, S.L. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21345534     DOI: 10.1016/j.eimc.2010.12.006

Source DB:  PubMed          Journal:  Enferm Infecc Microbiol Clin        ISSN: 0213-005X            Impact factor:   1.731


  2 in total

1.  Usefulness of Integrase resistance testing in proviral HIV-1 DNA in patients with Raltegravir prior failure.

Authors:  Jose Ángel Fernández-Caballero; Natalia Chueca; Marta Álvarez; María Dolores Mérida; Josefa López; José Antonio Sánchez; David Vinuesa; María Ángeles Martínez; José Hernández; Federico García
Journal:  BMC Infect Dis       Date:  2016-05-13       Impact factor: 3.090

2.  Improving Clinical Laboratory Efficiency: Introduction of Systems for the Diagnosis and Monitoring of HIV Infection.

Authors:  Marta Alvarez; Natalia Chueca; Vicente Guillot; María Del Carmen Bernal; Federico García
Journal:  Open Virol J       Date:  2012-11-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.